Remus Pharmaceuticals Ltd.

₹916.3

Remus Pharmaceuticals Ltd.

  • NSE : REMUS
Add Alert
Add Watchlist

₹916.3

₹916.3

32.6 (3.69%) - 18 Aug 2025 04:28 PM
  • NSE : REMUS

About Company

Remus Pharmaceuticals limited is engaged in marketing & distribution of finished formulations of pharmaceutical drugs. The company also deals in API (Active Pharmaceutical Ingredient). It also provides technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries. Having cultivated strong and dependable customer relationships ranging from Generic distributors, regional distributors and Multinational distributors to Hospitals and Clinics through a responsive distribution network, its clients are spread in various countries. It looks forward to form long lasting relationships that enhance the lives of its patients.

Market Cap. ₹ 1,080 Cr.
52 Week - High/Low ₹ 0/0
P/E Ratio 28.96
P/B Ratio 13.16
Enterprise Value ₹ 1,103 Cr.
ROE % 33.24
RSI Value 37.84
EMA 50 1234.32
EMA 200 1778.91
Market Cap. ₹ 1,080 Cr.
52 Week - High/Low ₹ 0/0
P/E Ratio 21.19
P/B Ratio 12.43
Enterprise Value ₹ 1,101 Cr.
ROE % 29.91
RSI Value 37.84
EMA 50 1234.32
EMA 200 1778.91

Valuation

Calculators

Peer Comparison

Industry - Trading

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Yearly

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.